Prostate cancer survivors who would be eligible for active surveillance but were either treated with radiotherapy or managed expectantly: comparisons on long-term quality of life and symptom burden.
about
Active surveillance for low-risk prostate cancer compared with immediate treatment: a Canadian cost comparison.Quality-of-life effects of prostate-specific antigen screening.Relationship between illness uncertainty, anxiety, fear of progression and quality of life in men with favourable-risk prostate cancer undergoing active surveillanceToward ethically responsible choice architecture in prostate cancer treatment decision-making.Radiotherapy in the management of prostate cancer after radical prostatectomy.Population-based cancer registries for quality-of-life research: a work-in-progress resource for survivorship studies?Expectant management for men with early stage prostate cancer.Prostate cancer detection by prostate-specific antigen-based screening in the Japanese Hiroshima area shows early stage, low-grade, and low rate of cancer-specific death compared with clinical detection.Long-term health-related quality of life of prostate cancer survivors varies by primary treatment. Results from the PiCTure (Prostate Cancer Treatment, your experience) study.Gleason score and tumor laterality in radical prostatectomy and transrectal ultrasound-guided biopsy of the prostate: a comparative study.Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial.Health-related quality of life among long-term (≥5 years) prostate cancer survivors by primary intervention: a systematic review.Anxiety and health-related quality of life (HRQL) in patients undergoing active surveillance of prostate cancer in an Australian centre.Sexual function with localized prostate cancer: active surveillance vs radical therapy.
P2860
Q33855285-0CE75999-F775-49AA-81A8-D97DDA7DEC14Q34294102-5973E566-AD7E-4E6D-8829-F1342AC453CEQ35991695-1D2FAAF4-D194-492F-944C-EF77FCE6C158Q36779782-1EE437FE-8389-4D52-AE70-E0CEB80E54CAQ38104412-00F28AF7-DB8A-4B62-B242-26769EB2CC71Q38108548-B649857C-8619-49E8-A41E-B36E3C31C337Q38469754-83F0C05A-DE0F-4F03-8CA2-42C4A9D5DA26Q40100788-9CF0C5FF-600A-4B6B-ACB6-1EB27CFD48CCQ41617693-EE286556-DD7D-4296-8627-1280906BFB87Q42139633-C1C5D921-C146-44F4-BB3F-89DCADD2E2C1Q45068930-55CD3A15-3386-4B95-B129-90776015AA24Q47555206-90F85590-6764-44A1-875E-497B0F90B216Q47866580-21651D0B-86C8-41D7-BF2F-A38719472497Q48494899-C3D08521-EA7F-4D56-910E-A498FF88B9AC
P2860
Prostate cancer survivors who would be eligible for active surveillance but were either treated with radiotherapy or managed expectantly: comparisons on long-term quality of life and symptom burden.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Prostate cancer survivors who ...... ty of life and symptom burden.
@en
Prostate cancer survivors who ...... ty of life and symptom burden.
@nl
type
label
Prostate cancer survivors who ...... ty of life and symptom burden.
@en
Prostate cancer survivors who ...... ty of life and symptom burden.
@nl
prefLabel
Prostate cancer survivors who ...... ty of life and symptom burden.
@en
Prostate cancer survivors who ...... ty of life and symptom burden.
@nl
P2093
P1433
P1476
Prostate cancer survivors who ...... ty of life and symptom burden.
@en
P2093
Floortje Mols
Ida J Korfage
Lonneke V van de Poll-Franse
Melissa S Y Thong
Paul J M Kil
P2860
P304
P356
10.1111/J.1464-410X.2009.08815.X
P577
2009-08-28T00:00:00Z